Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Frederick H.
Frederick H. Amidon, Jr., Cornish, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20110001780 | POSITIONING JETTING ASSEMBLIES - Among other things, in one aspect, an apparatus comprises features to enable mounting first and second jetting assemblies on a frame. The features comprise first and second alignment datums pre-fixed with respect to the frame for establishing respective positions of the first and second jetting assemblies, when mounted, so that at least some of the nozzles along a length of one of the jetting assemblies have predetermined offsets relative to at least some of the nozzles along a length of the other of the jetting assemblies, and an opening exposing all of the nozzles along the lengths of the first and second jetting assemblies are exposed to permit jetting of a fluid onto a substrate. | 01-06-2011 |
Frederick H. Bolay, Rancho Cordova, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20100223454 | METHOD AND APPARATUS FOR REMOVABLE DEVICE MODIFICATION OF SYSTEM CONFIGURATION - A method and apparatus for updating the system configuration settings of a computer system. Embodiments include a remote system configuration system that enables a user to update the system configuration of a target machine from a server machine over a network or similar communications system. Another embodiment includes a system configuration method using a bus master device to write system configuration data into a target computer system. | 09-02-2010 |
Frederick H. Brown, Glenburn, ME US
| Patent application number | Description | Published |
|---|---|---|
| 20090025617 | SYSTEM OF ACCESSORIES FOR MODEL TRAIN TABLE - A system of accessories to be used with a model train table having raised sides, said system comprising at least one perimeter section having a top member, an inner panel, and an outer panel, whereby the perimeter members are suitably adapted to be placed over and onto the sides of the model train table, such that portions of model train track may be placed onto the top members of the perimeter sections and graphic designs may be placed onto the outer faces of the panels of the perimeter sections. | 01-29-2009 |
Frederick H. Eggars, Sahuarita, AZ US
| Patent application number | Description | Published |
|---|---|---|
| 20110117553 | Methods for PCR and HLA typing using raw blood - Provided are methods for amplifying a gene or RNA or sets thereof of interest using a tandem PCR process. The primers in the first PCR or set of PCR reactions are locus-specific. The primers in the second PCR or set of PCR reactions are specific for a sub-sequence of the locus-specific primers and completely consumed during the secondary PCR amplification. For RNA amplification, the first PCR is reverse transcription and the resulting cDNA(s) provide a template for cRNA synthesis, endpoint PCR or real time PCR. Also provided is a method of allelotyping a gene or set thereof by amplifying the gene(s) using tandem PCR on DNA or RNA comprising the sample, hybridizing the resulting amplicon or sets thereof to probes with sequences of gene-associated allele variations. A detectable signal indicating hybridization corresponds to an allelotype of the gene or a set of allelotypes for the set of genes. | 05-19-2011 |
Frederick H. Fiesser, Collegeville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20100080897 | Continuous Coating of Pellets - A continuous dosage form coating apparatus uses vibrational impulses to maintain a dosage forms in a fluid state to expose them to a coating material atomized by spraying. | 04-01-2010 |
| 20110036858 | VAPOR SHEATH FOR LIQUID DISPENSING NOZZLE - The present disclosure provides a device for preventing the fouling of a liquid dispensing nozzle. The end of the dispensing nozzle is placed In a hollow interior of a band carrying the same solvents that are dispensed by the nozzle. The solvent on the band evaporates into a gap between the ring and the dispensing nozzle, thus providing a vapor sheath or environment that helps to prevent the fouling of the dispensing nozzle. | 02-17-2011 |
Frederick H. Hausheer, Boerne, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080261919 | Camptothecin-analog with a novel, "flipped" lactone-stable, E-ring and methods for making and using same - The present invention discloses: (i) a novel, lactone-stable, “flipped” E-ring camptothecin, pharmaceutically-acceptable salts, and/or analogs thereof; (ii) methods of synthesis of said novel, lactone-stable, “flipped” E-ring camptothecin, pharmaceutically-acceptable salts, and/or analogs thereof; (iii) pharmaceutically-acceptable formulations comprising said novel, lactone-stable, “flipped” E-ring camptothecin, pharmaceutically-acceptable salts, and/or analogs thereof, and, optionally, one or more additional chemotherapeutic agents; (iv) methods of administration of said novel, lactone-stable, “flipped” E-ring camptothecin, pharmaceutically-acceptable salts, and/or analogs thereof, and, optionally, one or more additional chemotherapeutic agents, to subjects in need thereof; and (v) devices for the administration of said novel, lactone-stable, “flipped” E-ring camptothecin, pharmaceutically-acceptable salts, and/or analogs thereof, and, optionally, one or more chemotherapeutic agents, to subjects in need thereof. | 10-23-2008 |
| 20090111735 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents - Novel compositions and formulations are disclosed that have use to mitigate or prevent physiologically deleterious side-effects and/or modulate the intracellular balance of oxidized and reduced thioredoxin (Trx) in patients with cancer who are receiving treatment with one or more chemotherapeutic agents. The compositions of matter are amino acid and peptide heteroconjugated disulfides of 2-mercaptoethane sulfonate sodium (mesna). In addition, methods of administration and kits comprising these novel mesna heteroconjugates are disclosed. | 04-30-2009 |
| 20090232827 | Compositions and methods of use of compounds to increase cancer patient survival time - The present invention discloses and claims compositions, methods of treatment, and kits which cause an increase in time of survival in cancer patients, wherein the cancer either: (i) overexpresses thioredoxin or glutaredoxin and/or (ii) exhibits evidence of thioredoxin- or glutaredoxin-mediated resistance to one or more chemotherapeutic interventions. The present invention also discloses and claims methods and kits for the administration of said compositions to properly treat cancer patients. Additionally, the present invention discloses and claims methods and kits for quantitatively determining the level of expression of thioredoxin or glutaredoxin in the cancer cells of a cancer patient, methods of using those determined levels in the initial diagnosis and/or planning of subsequent treatment methodologies for said cancer patient, as well as ascertaining the potential growth “aggressiveness” of the particular cancer and treatment responsiveness of the particular type of cancer. Further, the present invention discloses and claims novel pharmaceutical compositions, methods, and kits used for the treatment of patients with medical conditions and disease where there is the overexpression of thioredoxin and/or glutaredoxin, and wherein this overexpression is associated with deleterious physiological effects in the patients. | 09-17-2009 |
| 20090232906 | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions - The present invention discloses and claims: (i) compositions, methods, and kits which lead to an increase in patient survival time in cancer patients receiving chemotherapy; (ii) compositions and methods which cause cytotoxic or apoptotic potentiation of the anti-cancer activity of chemotherapeutic agents; (iii) compositions and methods for maintaining or stimulating hematological function in patients in need thereof, including those patients suffering from cancer; (iv) compositions and methods for maintaining or stimulating erythropoietin function or synthesis in patients in need thereof, including those patients suffering from cancer; (v) compositions and methods for mitigating or preventing anemia in patients in need thereof, including those patients suffering from cancer; (vi) compositions and methods for maintaining or stimulating pluripotent, multipotent, and unipotent normal stem cell function or synthesis in patients in need thereof, including those patients suffering from cancer; (vii) compositions and methods which promote the arrest or retardation of tumor progression in those cancer patients receiving chemotherapy; (viii) compositions and methods for increasing patient survival and/or delaying tumor progression while maintaining or improving the quality of life in a cancer patient receiving chemotherapy; (ix) novel methods of the administration of taxane and/or platinum medicaments and a Formula (I) compound of the present invention to a cancer patient; and (x) kits to achieve one or more of the aforementioned physiological effects in a patient in need thereof, including those patients suffering from cancer. | 09-17-2009 |
Frederick H. Selmon, Iii, Hamilton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090194513 | Method and apparatus for operating traveling spark igniter at high pressure - An ignition circuit and a method of operating an igniter (preferably a traveling spark igniter) in an internal combustion engine, including a high pressure engine. A high voltage is applied to electrodes of the igniter, sufficient to cause breakdown to occur between the electrodes, resulting in a high current electrical discharge in the igniter, over a surface of an isolator between the electrodes, and formation of a plasma kernel in a fuel-air mixture adjacent said surface. Following breakdown, a sequence of one or more lower voltage and lower current pulses is applied to said electrodes, with a low “simmer” current being sustained through the plasma between pulses, preventing total plasma recombination and allowing the plasma kernel to move toward a free end of the electrodes with each pulse. | 08-06-2009 |
Frederick H. Treesh, Carlsbad, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090286472 | Multi-Rate Downstreaming in Multiple Sub-Channel Environment - An embodiment of a satellite system for broadband communication with a plurality of remote locations is disclosed. The satellite system includes a satellite, a number of service spot beams from the satellite and a number of forward channels. Each of the number of forward channels is transported on a carrier in one of the plurality of service spot beams. The number of forward sub-channels pass on one of the number of forward channels. The size of the forward sub-channels varies over time. | 11-19-2009 |